53
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prognostic Value of Macrophage Inflammatory Protein-3alpha (MIP3-Alpha) and Severity Scores in Elderly Patients with Sepsis

ORCID Icon, ORCID Icon, , , ORCID Icon &
Pages 1503-1509 | Received 30 Oct 2023, Accepted 28 Feb 2024, Published online: 08 Mar 2024

References

  • Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200–211. doi:10.1016/S0140-6736(19)32989-7
  • Bauer M, Gerlach H, Vogelmann T, et al. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit Care. 2020;24(1):239. doi:10.1186/s13054-020-02950-2
  • Hausfater P, Robert Boter N, Morales Indiano C, et al. Monocyte distribution width (MDW) performance as an early sepsis indicator in the emergency department: comparison with CRP and procalcitonin in a multicenter international European prospective study. Crit Care. 2021;25(1):227. doi:10.1186/s13054-021-03622-5
  • Wong HR. Pediatric sepsis biomarkers for prognostic and predictive enrichment. Pediatr Res. 2022;91(2):283–288. doi:10.1038/s41390-021-01620-5
  • Barichello T, Generoso JS, Singer M, et al. Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review. Crit Care. 2022;26(1):14. doi:10.1186/s13054-021-03862-5
  • Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013;50(1):23–36. doi:10.3109/10408363.2013.764490
  • Herman L, Hubert P, Caberg J-H, et al. MIP3 alpha stimulates the migration of Langerhans cells in models of human papillomavirus (HPV)-associated (pre)neoplastic epithelium. Cancer Immunol Immunother. 2007;56(7):1087–1096. doi:10.1007/s00262-006-0255-2
  • Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063–e1143. doi:10.1097/CCM.0000000000005337
  • Uffen JW, Oosterheert JJ, Schweitzer VA, et al. Interventions for rapid recognition and treatment of sepsis in the emergency department: a narrative review. Clin Microbiol Infect. 2021;27(2):192–203. doi:10.1016/j.cmi.2020.02.022
  • Grebenchikov OA, Kuzovlev AN. Long-term outcomes after sepsis. Biochemistry. 2021;86(5):563–567. doi:10.1134/S0006297921050059
  • Shimazui T, Nakada T-A, Walley KR, et al. Significance of body temperature in elderly patients with sepsis. Crit Care. 2020;24(1):387. doi:10.1186/s13054-020-02976-6
  • Pierrakos C, Velissaris D, Bisdorff M, et al. Biomarkers of sepsis: time for a reappraisal. Crit Care. 2020;24(1):287. doi:10.1186/s13054-020-02993-5
  • Luzzani A, Polati E, Dorizzi R, et al. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003;31(6):1737–1741. doi:10.1097/01.CCM.0000063440.19188.ED
  • Park JH, Kim DH, Jang HR, et al. Clinical relevance of procalcitonin and C-reactive protein as infection markers in renal impairment: a cross-sectional study. Crit Care. 2014;18(6):640. doi:10.1186/s13054-014-0640-8
  • Menon K, Schlapbach LJ, Akech S, et al. Criteria for pediatric sepsis-A systematic review and meta-analysis by the pediatric sepsis definition taskforce. Crit Care Med. 2022;50(1):21–36. doi:10.1097/CCM.0000000000005294
  • Chan YL, Liao H-C, Tsay P-K, et al. C-reactive protein as an indicator of bacterial infection of adult patients in the emergency department. Chang Gung Med J. 2002;25(7):437–445.
  • Lee AY, Phan TK, Hulett MD, et al. The relationship between CCR6 and its binding partners: does the CCR6-CCL20 axis have to be extended? Cytokine. 2015;72(1):97–101. doi:10.1016/j.cyto.2014.11.029
  • Ito T, Carson WF, Cavassani KA, et al. CCR6 as a mediator of immunity in the lung and gut. Exp Cell Res. 2011;317(5):613–619. doi:10.1016/j.yexcr.2010.12.018
  • Lee AYS, Körner H. The CCR6-CCL20 axis in humoral immunity and T-B cell immunobiology. Immunobiology. 2019;224(3):449–454. doi:10.1016/j.imbio.2019.01.005
  • Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003;14(5):409–426. doi:10.1016/S1359-6101(03)00049-2
  • Li L, Zhou J, Xu Y, et al. C-C chemokine receptor type 6 modulates the biological function of osteoblastogenesis by altering the expression levels of Osterix and OPG/RANKL. Biosci Trends. 2021;15(4):240–248. doi:10.5582/bst.2021.01199
  • Zhao X, Li Y, Wang X, et al. Synergistic association of FOXP3+ tumor infiltrating lymphocytes with CCL20 expressions with poor prognosis of primary breast cancer: a retrospective cohort study. Medicine. 2019;98(50):e18403. doi:10.1097/MD.0000000000018403
  • Fennen M, Weinhage T, Kracke V, et al. A myostatin-CCL20-CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis. Sci Rep. 2021;11(1):14145. doi:10.1038/s41598-021-93599-6
  • Kitagawa Y, Kikuchi S, Arita Y, et al. Inhibition of CCL20 increases mortality in models of mouse sepsis with intestinal apoptosis. Surgery. 2013;154(1):78–88. doi:10.1016/j.surg.2013.02.012
  • Tack BF, Malik ZA. Structure of human MIP‐3α chemokine. Acta Crystallographica Section F. 2006;62:631–634.
  • Klein M, Brouwer MC, Angele B, et al. Leukocyte attraction by CCL20 and its receptor CCR6 in humans and mice with pneumococcal meningitis. PLoS One. 2014;9(4):e93057. doi:10.1371/journal.pone.0093057
  • Crispo M, Van Maele L, Tabareau J, et al. Transgenic mouse model harboring the transcriptional fusion ccl20-luciferase as a novel reporter of pro-inflammatory response. PLoS One. 2013;8(11):e78447. doi:10.1371/journal.pone.0078447
  • Hammerich L, Bangen JM, Govaere O, et al. Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis. Hepatology. 2014;59(2):630–642. doi:10.1002/hep.26697
  • Klaus DA, Seemann R, Roth-Walter F, et al. Plasma levels of chemokine ligand 20 and chemokine receptor 6 in patients with sepsis: a case control study. Eur J Anaesthesiol. 2016;33(5):348–355. doi:10.1097/EJA.0000000000000388
  • Gaini S, Relster MM, Pedersen C, et al. Prediction of 28-days mortality with sequential organ failure assessment (SOFA), quick SOFA (qSOFA) and systemic inflammatory response syndrome (SIRS) - A retrospective study of medical patients with acute infectious disease. Int J Infect Dis. 2019;78:1–7. doi:10.1016/j.ijid.2018.09.020
  • Karakike E, Kyriazopoulou E, Tsangaris I, et al. The early change of SOFA score as a prognostic marker of 28-day sepsis mortality: analysis through a derivation and a validation cohort. Crit Care. 2019;23(1):387. doi:10.1186/s13054-019-2665-5
  • Raith EP, Udy AA, Bailey M, et al. Prognostic accuracy of the SOFA Score, SIRS Criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA. 2017;317(3):290–300. doi:10.1001/jama.2016.20328
  • Zhang Y, Wang J, Yu B-Z, et al. Predictive value of heart-type fatty acid-binding protein for mortality risk in critically ill patients. Dis Markers. 2022;2022:1720414. doi:10.1155/2022/1720414